Metabolism of Carfentanil, an Ultra-Potent Opioid, in Human Liver Microsomes and Human Hepatocytes by High-Resolution Mass Spectrometry
- 5 August 2016
- journal article
- Published by Springer Nature in The AAPS Journal
- Vol. 18 (6) , 1489-1499
Abstract
Carfentanil is an ultra-potent synthetic opioid. No human carfentanil metabolism data are available. Reportedly, Russian police forces used carfentanil and remifentanil to resolve a hostage situation in Moscow in 2002. This alleged use prompted interest in the pharmacology and toxicology of carfentanil in humans. Our study was conducted to identify human carfentanil metabolites and to assess carfentanil's metabolic clearance, which could contribute to its acute toxicity in humans. We used Simulations Plus's ADMET Predictor™ and Molecular Discovery's MetaSite™ to predict possible metabolite formation. Both programs gave similar results that were generally good but did not capture all metabolites seen in vitro. We incubated carfentanil with human hepatocytes for up to 1 h and analyzed samples on a Sciex 3200 QTRAP mass spectrometer to measure parent compound depletion and extrapolated that to represent intrinsic clearance. Pooled primary human hepatocytes were then incubated with carfentanil up to 6 h and analyzed for metabolite identification on a Sciex 5600+ TripleTOF (QTOF) high-resolution mass spectrometer. MS and MS/MS analyses elucidated the structures of the most abundant metabolites. Twelve metabolites were identified in total. N-Dealkylation and monohydroxylation of the piperidine ring were the dominant metabolic pathways. Two N-oxide metabolites and one glucuronide metabolite were observed. Surprisingly, ester hydrolysis was not a major metabolic pathway for carfentanil. While the human liver microsomal system demonstrated rapid clearance by CYP enzymes, the hepatocyte incubations showed much slower clearance, possibly providing some insight into the long duration of carfentanil's effects.Keywords
This publication has 28 references indexed in Scilit:
- An Automated Liquid Chromatography-Mass Spectrometry Process to Determine Metabolic Stability Half-Life and Intrinsic Clearance of Drug Candidates by Substrate DepletionASSAY and Drug Development Technologies, 2008
- PHARMACOKINETICS AND PHARMACODYNAMICS OF CARFENTANIL AND NALTREXONE IN FEMALE COMMON ELAND (TAUROTRAGUS ORYX)Journal of Zoo and Wildlife Medicine, 2006
- Identification of Fentanyl, Alfentanil, Sufentanil, Remifentanil and Their Major Metabolites in Human Urine by Liquid Chromatography/Tandem Mass Spectrometry for Doping Control PurposesEuropean Journal of Mass Spectrometry, 2005
- Highly sensitive gas chromatographic—mass spectrometric screening method for the determination of picogram levels of fentanyl, sufentanil and alfentanil and their major metabolites in urine of opioid exposed workersJournal of Chromatography B, 2004
- Quantification of brain μ-opioid receptors with [11C]carfentanil: reference-tissue methodsNuclear Medicine and Biology, 2003
- Molecular Docking Reveals a Novel Binding Site Model for Fentanyl at the μ-Opioid ReceptorJournal of Medicinal Chemistry, 2000
- RemifentanilAnesthesia & Analgesia, 1996
- RemifentanilAnesthesia & Analgesia, 1996
- EXPLANATION FOR POTENCY OF REPEATED ORAL DOSES OF MORPHINE?The Lancet, 1987
- Tissue Redistribution of Fentanyl and Termination of Its Effects in RatsAnesthesiology, 1981